Figure 1.
OS of patients with APL with extreme hyperleukocytosis. Survival stratified by (A) ATO-based therapy, (B) early vs late era, (C) ATO-based therapy and age, (D) ATO-based therapy and early vs late era.
OS of patients with APL with extreme hyperleukocytosis. Survival stratified by (A) ATO-based therapy, (B) early vs late era, (C) ATO-based therapy and age, (D) ATO-based therapy and early vs late era.
